NR3C1 and cervical carcinoma: By employing fluorescence polarization competitive binding assay and immunofluorescence assay, the group reported a dose-dependent binding of BoA to the GR in HeLa human cervical cancer cells followed by the nuclear translocation of the resulting BoA-GR complex from the cytoplasm.